Gainers
- Enzo Biochem ENZ stock moved upwards by 12.5% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $76.0 million.
- Avinger AVGR shares rose 10.1% to $0.86. The company's market cap stands at $9.1 million.
- NextGen Healthcare NXGN shares increased by 8.89% to $18.0. The market value of their outstanding shares is at $1.1 billion. The company's, Q1 earnings came out today.
- iSpecimen ISPC stock rose 6.87% to $1.4. The market value of their outstanding shares is at $12.6 million.
- Ra Medical Systems RMED shares rose 6.56% to $0.72. The company's market cap stands at $4.6 million.
- Plus Therapeutics PSTV stock increased by 6.13% to $2.25. The market value of their outstanding shares is at $5.6 million.
Losers
- NeuroOne Medical Tech NMTC stock fell 27.1% to $1.16 during Monday's after-market session. Trading volume for this security closed at 163.1K, accounting for 102.5% of its average full-day volume over the last 100 days. The company's market cap stands at $20.3 million.
- Medpace Hldgs MEDP stock declined by 8.89% to $225.0. The company's market cap stands at $6.8 billion. As per the news, the Q2 earnings report came out today.
- Etao International Co ETAO shares fell 7.9% to $0.46. Etao International Co's trading volume hit 101.4K shares by close, accounting for 19.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $47.0 million.
- Biodexa Pharmaceuticals BDRX shares declined by 6.21% to $6.05. The market value of their outstanding shares is at $1.4 million.
- NexImmune NEXI stock fell 6.05% to $0.28. The market value of their outstanding shares is at $7.3 million.
- Armata Pharmaceuticals ARMP shares declined by 5.1% to $1.49. The company's market cap stands at $53.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in